FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status
โ Scribed by Gentian Kaloshi; Karima Mokhtari; Catherine Carpentier; Sophie Taillibert; Julie Lejeune; Yannick Marie; Jean-Yves Delattre; Roseline Godbout; Marc Sanson
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 189 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Molecular prognostic indicators for oropharyngeal squamous cell carcinoma (OSCC), including HPVโDNA detection, epidermal growth factor receptor (EGFR) and p16 expression, have been suggested in the literature, but none of these are currently used in clinical practice. To compare these p
## Abstract __KRAS__ mutations are a strong predictive marker of resistance to antiโepidermal growth factor receptor (EGFR) antibodies in advanced colorectal cancer (CRC) but only a subset of wildโtype (WT) __KRAS__ patients are responders, suggesting the existence of additional markers of resistan
Repair of cytotoxic DNA damage by O 6 -methylguanine-DNA methyltransferase (MGMT) is a potentially important factor of chemoresistance to chloroethylnitrosoureas (CE-NUs), commonly used in the treatment of glioblastoma multiforme (GBM). The value of p53 as a prognostic factor in GBMs remains unclear